Data / Form D filings / Viamet Pharmaceuticals Inc
Viamet Pharmaceuticals Inc: Form D filings
Viamet Pharmaceuticals Inc, a pharmaceuticals company in Morrisville, NC, filed 2 Form D notices with the SEC between 2009 and 2011. The latest, on February 18, 2011, reports $25 million sold of a $25 million offering to 7 investors.
Find out what Viamet Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2250 PERIMETER PARK DRIVE, SUITE 320, Morrisville, NC, 27560
- Phone
- (919) 467-8539
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1336674
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2011 | Amendment | $24,999,997 | $24,999,997 | $0 | 7 | Jun 23, 2009 | sec.gov |
| Jul 7, 2009 | New notice | $17,999,996 | $9,999,997 | $7,999,999 | 7 | Jun 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| S. Edward T. Torres | Director | |
| Robert Schotzinger | Executive Officer, Director | |
| William T. White, III | Director | |
| Lauren T. Silverman | Director | |
| Douglas Reed | Director | |
| James Rosen | Director | |
| Neil T. Moore | Executive Officer | |
| Andrew T. von Eschenbach | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Feb 14, 2011 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Viamet Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.